Shanghai INT Medical Instruments Co (HKSE:01501) Total Liabilities : HK$505.4 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Total Liabilities?

Shanghai INT Medical Instruments Co's Total Liabilities for the quarter that ended in Dec. 2024 was HK$505.4 Mil.

Shanghai INT Medical Instruments Co's quarterly Total Liabilities declined from Dec. 2023 (HK$384.19 Mil) to Jun. 2024 (HK$295.74 Mil) but then increased from Jun. 2024 (HK$295.74 Mil) to Dec. 2024 (HK$505.42 Mil).

Shanghai INT Medical Instruments Co's annual Total Liabilities increased from Dec. 2022 (HK$305.12 Mil) to Dec. 2023 (HK$384.19 Mil) and increased from Dec. 2023 (HK$384.19 Mil) to Dec. 2024 (HK$505.42 Mil).

Shanghai INT Medical Instruments Co Total Liabilities Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Total Liabilities Chart

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

112.66

224.84

305.12

384.19

505.42

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial										305.12	374.30	384.19	295.74	505.42

Shanghai INT Medical Instruments Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai INT Medical Instruments Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	463.857	+	(16.575	+	24.992
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	505.4

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2412.812	-	1907.388
	=	505.4

Shanghai INT Medical Instruments Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	463.857	+	(16.575	+	24.992
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	505.4

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	2412.812	-	1907.388
	=	505.4

Shanghai INT Medical Instruments Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.int-medical.com

Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.

Executives

Jpmorgan Chase & Co.	2106 Person having a security interest in shares
China Orient Asset Management (international) Holding Limited	2201 Interest of corporation controlled by you
Zhao Wei	2202 Interest of your spouse
Wang Kai	2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership)	2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Orbimed Capital Llc	2102 Investment manager
Zhao Wei	2202 Interest of your spouse
Zheng Aiping	2501 Other
Zhang Xianmiao	2501 Other
Zhang Wei	2501 Other
Shanghai Kindly Holding Group Co., Ltd.	2201 Interest of corporation controlled by you
Worldwide Healthcare Trust Plc	2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines